Does palm oil vitamin E reduce the risk of pregnancy induced hypertension?

Zaleha Abdullah Mahdy, Harlina Halizah Siraj @ Ramli, Huzwah Khaza'ai, Mohd Sokhini Abdul Mutalib, Muhammad Hatta Azwar, Marianah Abdul Wahab, Ahmad Zailani Hatta Md Dali, Rohana Jaafar, Nor Azlin Mohamed Ismail, Muhammad Abdul Jamil, Nafisah Adeeb

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

In view of the high anti-oxidative potential oftocotrienol, the role of the tocotrienol-rich fraction (TRF) of palm oil in preventing pregnancy induced hypertension (PIH) was explored in a randomized double-blind placebo-controlled clinical trial in an urban teaching hospital. Healthy primigravidae were randomized to receive either oral TRF 100 mg daily or placebo, from early second trimester until delivery. Out of 299 women, 151 were randomized into the TRF arm and 148 into the placebo arm. A total of 15 (5.0%) developed PIH. Although there was no statistically significant difference in the incidence of PIH (4/151 or 2.6% in the TRF arm vs. 11/148 or 7.4% in the placebo arm, p = 0.058) between the two arms, there was a tendency towards a lower incidence of PIH in the TRF arm compared to the placebo arm. With TRF supplementation, the relative risk (RR) of PIH was 0.36 (95% CI 0.12-1.09). In conclusion, although TRF from palm oil does not statistically significantly reduce the risk of development of PIH in the population studied, the 64% reduction in incidence of PIH is substantial. The findings warrant further clinical trials, particularly in high risk populations.

Original languageEnglish
Pages (from-to)104-109
Number of pages6
JournalActa medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové
Volume56
Issue number3
Publication statusPublished - 2013

Fingerprint

Tocotrienols
Pregnancy Induced Hypertension
Vitamin E
Placebos
Incidence
Urban Hospitals
Controlled Clinical Trials
Second Pregnancy Trimester
palm oil
Teaching Hospitals
Population
Clinical Trials

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Does palm oil vitamin E reduce the risk of pregnancy induced hypertension? / Abdullah Mahdy, Zaleha; Siraj @ Ramli, Harlina Halizah; Khaza'ai, Huzwah; Mutalib, Mohd Sokhini Abdul; Azwar, Muhammad Hatta; Wahab, Marianah Abdul; Dali, Ahmad Zailani Hatta Md; Jaafar, Rohana; Mohamed Ismail, Nor Azlin; Jamil, Muhammad Abdul; Adeeb, Nafisah.

In: Acta medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové, Vol. 56, No. 3, 2013, p. 104-109.

Research output: Contribution to journalArticle

Abdullah Mahdy, Zaleha ; Siraj @ Ramli, Harlina Halizah ; Khaza'ai, Huzwah ; Mutalib, Mohd Sokhini Abdul ; Azwar, Muhammad Hatta ; Wahab, Marianah Abdul ; Dali, Ahmad Zailani Hatta Md ; Jaafar, Rohana ; Mohamed Ismail, Nor Azlin ; Jamil, Muhammad Abdul ; Adeeb, Nafisah. / Does palm oil vitamin E reduce the risk of pregnancy induced hypertension?. In: Acta medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové. 2013 ; Vol. 56, No. 3. pp. 104-109.
@article{8f97b5cd5f3f45828bd0b59b87604456,
title = "Does palm oil vitamin E reduce the risk of pregnancy induced hypertension?",
abstract = "In view of the high anti-oxidative potential oftocotrienol, the role of the tocotrienol-rich fraction (TRF) of palm oil in preventing pregnancy induced hypertension (PIH) was explored in a randomized double-blind placebo-controlled clinical trial in an urban teaching hospital. Healthy primigravidae were randomized to receive either oral TRF 100 mg daily or placebo, from early second trimester until delivery. Out of 299 women, 151 were randomized into the TRF arm and 148 into the placebo arm. A total of 15 (5.0{\%}) developed PIH. Although there was no statistically significant difference in the incidence of PIH (4/151 or 2.6{\%} in the TRF arm vs. 11/148 or 7.4{\%} in the placebo arm, p = 0.058) between the two arms, there was a tendency towards a lower incidence of PIH in the TRF arm compared to the placebo arm. With TRF supplementation, the relative risk (RR) of PIH was 0.36 (95{\%} CI 0.12-1.09). In conclusion, although TRF from palm oil does not statistically significantly reduce the risk of development of PIH in the population studied, the 64{\%} reduction in incidence of PIH is substantial. The findings warrant further clinical trials, particularly in high risk populations.",
author = "{Abdullah Mahdy}, Zaleha and {Siraj @ Ramli}, {Harlina Halizah} and Huzwah Khaza'ai and Mutalib, {Mohd Sokhini Abdul} and Azwar, {Muhammad Hatta} and Wahab, {Marianah Abdul} and Dali, {Ahmad Zailani Hatta Md} and Rohana Jaafar and {Mohamed Ismail}, {Nor Azlin} and Jamil, {Muhammad Abdul} and Nafisah Adeeb",
year = "2013",
language = "English",
volume = "56",
pages = "104--109",
journal = "Acta medica (Hradec Kralove)",
issn = "1211-4286",
publisher = "Vydavatelstvi Karolinum",
number = "3",

}

TY - JOUR

T1 - Does palm oil vitamin E reduce the risk of pregnancy induced hypertension?

AU - Abdullah Mahdy, Zaleha

AU - Siraj @ Ramli, Harlina Halizah

AU - Khaza'ai, Huzwah

AU - Mutalib, Mohd Sokhini Abdul

AU - Azwar, Muhammad Hatta

AU - Wahab, Marianah Abdul

AU - Dali, Ahmad Zailani Hatta Md

AU - Jaafar, Rohana

AU - Mohamed Ismail, Nor Azlin

AU - Jamil, Muhammad Abdul

AU - Adeeb, Nafisah

PY - 2013

Y1 - 2013

N2 - In view of the high anti-oxidative potential oftocotrienol, the role of the tocotrienol-rich fraction (TRF) of palm oil in preventing pregnancy induced hypertension (PIH) was explored in a randomized double-blind placebo-controlled clinical trial in an urban teaching hospital. Healthy primigravidae were randomized to receive either oral TRF 100 mg daily or placebo, from early second trimester until delivery. Out of 299 women, 151 were randomized into the TRF arm and 148 into the placebo arm. A total of 15 (5.0%) developed PIH. Although there was no statistically significant difference in the incidence of PIH (4/151 or 2.6% in the TRF arm vs. 11/148 or 7.4% in the placebo arm, p = 0.058) between the two arms, there was a tendency towards a lower incidence of PIH in the TRF arm compared to the placebo arm. With TRF supplementation, the relative risk (RR) of PIH was 0.36 (95% CI 0.12-1.09). In conclusion, although TRF from palm oil does not statistically significantly reduce the risk of development of PIH in the population studied, the 64% reduction in incidence of PIH is substantial. The findings warrant further clinical trials, particularly in high risk populations.

AB - In view of the high anti-oxidative potential oftocotrienol, the role of the tocotrienol-rich fraction (TRF) of palm oil in preventing pregnancy induced hypertension (PIH) was explored in a randomized double-blind placebo-controlled clinical trial in an urban teaching hospital. Healthy primigravidae were randomized to receive either oral TRF 100 mg daily or placebo, from early second trimester until delivery. Out of 299 women, 151 were randomized into the TRF arm and 148 into the placebo arm. A total of 15 (5.0%) developed PIH. Although there was no statistically significant difference in the incidence of PIH (4/151 or 2.6% in the TRF arm vs. 11/148 or 7.4% in the placebo arm, p = 0.058) between the two arms, there was a tendency towards a lower incidence of PIH in the TRF arm compared to the placebo arm. With TRF supplementation, the relative risk (RR) of PIH was 0.36 (95% CI 0.12-1.09). In conclusion, although TRF from palm oil does not statistically significantly reduce the risk of development of PIH in the population studied, the 64% reduction in incidence of PIH is substantial. The findings warrant further clinical trials, particularly in high risk populations.

UR - http://www.scopus.com/inward/record.url?scp=84900799954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900799954&partnerID=8YFLogxK

M3 - Article

C2 - 24592747

AN - SCOPUS:84900799954

VL - 56

SP - 104

EP - 109

JO - Acta medica (Hradec Kralove)

JF - Acta medica (Hradec Kralove)

SN - 1211-4286

IS - 3

ER -